Skip to main content
Clinical Trials/NL-OMON23631
NL-OMON23631
Recruiting
Not Applicable

Biomarker-based Early Anti-inflammatory Therapy for severe COVID-19

Prof. Dr. L.G. Visser0 sites250 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
coronavirus
Sponsor
Prof. Dr. L.G. Visser
Enrollment
250
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Prof. Dr. L.G. Visser

Eligibility Criteria

Inclusion Criteria

  • Hospitalized patient with PCR confirmed COVID\-19 infection
  • \- Eighteen years or older

Exclusion Criteria

  • \- Not able to give consent by representative of the subject

Outcomes

Primary Outcomes

Not specified

Similar Trials